Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
Sole agencyRecompete exposure: Moderate · 2 in 24mo
Hot Shots Nm has an estimated $367K in contracts returning to market over the next 24 months.
Agency buyer map
1 buyersRecompete exposure
ModerateHot Shots Nm has an estimated $367K in contracts returning to market over the next 24 months. 2 within 6 months ($367K).
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Hot Shots Nm hold?
Hot Shots Nm (UEI MKESZ56EH4Q1) shows $1.0M across 18 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Hot Shots Nm have?
Hot Shots Nm shows $1.0M across 18 award actions. SCOUT tracks 2 incumbent recompetes ($367K) returning to market in the next 24 months.
Which agencies does Hot Shots Nm work with?
Hot Shots Nm’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (100%).
What is the UEI for Hot Shots Nm?
The Unique Entity ID (UEI) for Hot Shots Nm is MKESZ56EH4Q1.
Does Hot Shots Nm have contracts coming up for recompete?
Yes — SCOUT tracks 2 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.